SARAH LAROSE: Open Payments
NPI 1285265587 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 27 payments from 9 companies in 2025. Trend: 2023 $209 · 2024 $644 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $213 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Lundbeck LLC | 2 | $57 |
| Janssen Pharmaceuticals, Inc | 2 | $55 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: VRAYLAR, REXULTI, SPRAVATO, FANAPT, TRINTELLIX, UZEDY, Qelbree, Auvelity.
Industry payments across NY — which companies pay providers there.
